With Reports Of Death, FDA Warns Multiple Sclerosis (MS) Patients Against Pharmaceutical Drug Tysabri

Greg Jones & Associates, a North Carolina-based law firm, in association with http://www.lawyersandsettlements.com, launches a marketing campaign to increase awareness of the Multiple Sclerosis drug, Tysabri. Makers of Tysabri, Biogen Idec Inc. and Elan Pharmaceuticals Inc., have recently taken the drug off the market and sent out warnings to doctors. In November 2004, Biogen Idec […]

This article is only available to members. Please Login or register.